Biologic Contract Manufacturing Webinar

Posted on May 28, 2024

June 6, 2024, 10:00 a.m. – 12:00 p.m. EST

Michael Hausladen, PhD, General Manager,
LOTTE Biologics

Michael Hausladen is the General Manager for LOTTE Biologics USA, LLC, headquartered in Syracuse, NY. LOTTE Biologics is a Contract Development and Manufacturing Organization that is serving the biologic pharmaceutical market. Previous roles at Bristol Myers Squibb (BMS) included starting up the Devens, MA $350M Cell Therapy Facility, managing clinical external biologics manufacturing and various leadership roles including Director of Manufacturing and Director of Manufacturing Technology.

Prior to working in biologics, Michael worked at BMS scaling up and commercialization of enzyme catalyzed and traditional organic synthesis of active pharmaceutical ingredients. Michael has a PhD in chemical engineering from the University at Buffalo.

Other Network News

November 4, 2026

Excellus BlueCross BlueShield Names Dr. Tenbit Emiru Chief Medical Officer

Tenbit Emiru, MD, PhD, MBA has joined Excellus BCBS and its parent company, The Lifetime Healthcare Companies, as enterprise chief medical officer and senior vice president of medical services.

November 4, 2026

AmeriCU Credit Union Announces Promotion of Daniela Paparo to Financial Center Manager

In this role, Daniela will lead the financial center team in supporting members’ financial needs and building strong relationships within the community.

November 2, 2026

Nave Law Firm Recognizes ED23 Foundation as November's Nave's Neighbor

Nave Law Firm recognizes the ED23 Foundation, founded by SU standout Eric Devendorf, for supporting Syracuse youth and families through sports, mentorship, and its Annual Turkey Drive.